AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Lumexa Imaging Holdings, Inc. Common Stock
Video analysis: LMRI
All videosNo video analysis for this stock yet. Request one from our team.
News: LMRI
BlackRock Inc. Takes $15.77 Million Position in Lumexa Imaging Holdings, Inc. $LMRI
BlackRock Inc. bought a new position in shares of Lumexa Imaging Holdings, Inc. (NASDAQ: LMRI) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,398,112 shares of the company's stock, valued at approximately $15,771,000. BlackRock Inc. owned approximately 1.46%
Lumexa Imaging Announces Participation in Upcoming Investor Conferences
RALEIGH, N.C., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging Holdings, Inc. (“Lumexa Imaging”) (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, announced today that Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the following upcoming investor conferences: Wells Fargo 21st Annual Healthcare Conference, held in Boston, including a fireside chat at 3:00 PM ET and one-on-one meetings with Caitlin Zulla and Tony Martin on September 9, 2026.
Wall Street Analysts See a 36.88% Upside in Lumexa (LMRI): Can the Stock Really Move This High?
The consensus price target hints at a 36.9% upside potential for Lumexa (LMRI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Lumexa Imaging Holdings, Inc. (LMRI) Q2 2026 Earnings Call Transcript
Lumexa Imaging Holdings, Inc. (LMRI) Q2 2026 Earnings Call Transcript
Lumexa Imaging Q2 Earnings Call Highlights
Lumexa Imaging NASDAQ: LMRI reported second-quarter revenue growth, higher advanced-imaging volumes and a return to profitability, while narrowing its full-year adjusted EBITDA outlook and reiterating revenue and adjusted earnings-per-share guidance.
Lumexa Imaging Announces Second Quarter 2026 Results
RALEIGH, N.C., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today reported results for the second quarter ended June 30, 2026, and updated its full year 2026 outlook.
Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date
RALEIGH, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its second quarter 2026 financial and operational results after market close on Wednesday, August 12, 2026.
4 Medical Products Stocks Poised to Win Despite Industry Headwinds
Terumo, QuidelOrtho, Lumexa Imaging and BrainsWay are tackling industry headwinds through innovation, pricing and execution as healthcare demand stays resilient.
Similar companies
-
Boston Scientific Corporation
BSX
·
New York Stock Exchange
Compare
-
BrainsWay Ltd.
BWAY
·
NASDAQ
Compare
-
Co-Diagnostics, Inc.
CODX
·
NASDAQ
Compare
-
Inspire Medical Systems, Inc.
INSP
·
New York Stock Exchange
Compare
-
iRhythm Technologies, Inc.
IRTC
·
NASDAQ
Compare
-
Picard Medical, Inc.
PMI
·
New York Stock Exchange Arca
Compare